Both in Pharmaceuticals
Context Therapeutics vs IGC Pharma
Over the past year CNTX returned −82.5% and IGC returned −54.0%; their daily moves had a correlation of 0.03.
CNTX −82.5% IGC −54.0%Growth of $1, one year, split-adjusted
| Metric | CNTX | IGC |
|---|---|---|
| Price | $0.1891 | $0.1850 |
| Market cap | $17.4M | $19.1M |
| Today | −6.25% | −7.13% |
| 1 month | −39.9% | −31.5% |
| 6 months | −91.7% | −44.8% |
| Year to date | −87.1% | −34.3% |
| 1 year | −83.6% | −54.2% |
| Revenue growth (YoY) | — | −19.2% |
| Gross margin | — | 18.1% |
| Net margin | — | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $43.0M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | 63.5% |
| Short % of float | 6.2% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).